Ready to cut time to save lives? Request consultation
Future-proof Healthcare
CEO Jonas Jarvius explains how Q-linea is intimately tied to his experiences of healthcare inequity, and how Q-linea is working to ensure we have sustainable and equitable healthcare, now and in the future.
“A huge advantage”
Listen to Ehsan Ghaderi, Head of Department, and Sofia Persson, Consultant Physician, Bacteriology Uppsala University Hospital, talks about how ASTar have helped save time in the lab.
“You will be much faster in adjusting the treatment”
Listen to Martin Sundqvist, Senior consultant, PhD, Clinical Microbiology, Örebro University Hospital. President of the Swedish Society of Clinical Microbiology speak about the value of rapid AST, true MIC values and more.
Find more words about us here
News & events
Interim report 1 January – 30 June 2022
Invitation to presentation of Q-linea’s Interim report Q2-2022 on July 14, 2022
Q-linea receives letter of intent to evaluate and potential commercialization of Podler
Q-linea AB (publ) (OMX: QLINEA) today announces that the company has received a Letter of Intent (LOI) for the…
Read more >
Q-linea as an investment
Q-linea is an innovative infection diagnostics company whose ambition is to offer products that benefit patients, healthcare providers and society.
Get in touch
We are happy to help. Please contact us with any questions or queries, we are just a click away.Q-linea as an investment
Q-linea is an innovative infection diagnostics company whose ambition is to offer products that benefit patients, healthcare providers and society.
Get in touch
We are happy to help. Please contact us with any questions or queries, we are just a click away.